Healthcare Law Faces First Challenge/Johnson & Johnson and the Breast Cancer Link

Crosstalk Home

Show Information

Air Date: May 10, 2011

Host: Jim Schneider

Guests: Mat Staver and Karen Malec

Listen: Real Audio | Windows Media | MP3

Mat Staver, founder and chairman of Liberty Counsel appeared on the first segment of this edition of Crosstalk after arguing in the Fourth Circuit Court of Appeals in the first legal challenge against the federal healthcare law (Liberty University vs. Geithner).

The crux of the problem in this case centers around the idea that Obamacare would force people, via federal law, into the stream of commerce in order to purchase health insurance.

Mat was followed by Karen Malec, president and co-founder of The Coalition on Abortion/Breast Cancer. The Coalition on Abortion/Breast Cancer is an international women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.

Karen appeared on Crosstalk to discuss the decision by the shareholders of Johnson & Johnson to continue selling cancer-causing hormonal contraceptives (birth-control pills). This cancer connection has been shown scientifically by both the World Health Organization as well as the Mayo Clinic. Karen also explains the science behind why abortion increases a woman’s chances of contracting what’s known as “triple-negative” breast cancer.

More Information

Liberty Counsel website:
www.lc.org

Karen Malec contact information:
1-877-803-0102
response@abortionbreastcancer.com (e-mail)
www.AbortionBreastCancer.com

To contact Johnson & Johnson about their sales of birth control pills:
William Welden
Johnson & Johnson
1 Johnson & Johnson Blvd.
New Brunswick, NJ 08933
732-524-0400

Order Information

To order today’s program on CD for a donation of $6.00

Temporarily, until our full website is updated, orders can be accepted only by mail or phone.

By mail:

Crosstalk
3434 W. Kilbourn Ave.
Milwaukee, WI 53208

By phone: 1-800-729-9829 M-F 8am-5pm Central

Leave a Reply